The UK-US medicines deal and the hidden costs of Brexit
Argues the UK–US medicines deal will cause the NHS to pay more for new drugs and presents this as an unrecognised cost of Brexit, outlining the deal’s implications for UK healthcare spending.
Everything government, Parliament, the statistical agencies and the major policy institutes published — read, summarised and ranked so you can skim the day in a minute.
2,019 articles · 39 live sources · updated Just now
Argues the UK–US medicines deal will cause the NHS to pay more for new drugs and presents this as an unrecognised cost of Brexit, outlining the deal’s implications for UK healthcare spending.